Baidu
map
MOL DIAGN THER 润色咨询

Molecular Diagnosis & Therapy

出版年份:2006 年文章数:448 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:3.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=31f64957, cover=https://img.medsci.cn/images/journal/cover/2021/iFm_202109271316062040.jpg, fullname=Molecular Diagnosis & Therapy, abbr=MOL DIAGN THER, pyear=2006, frequence=Bimonthly, articleNumbers=448, citedSelf2015=3.3, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1177-1062, greenSci=https://www.greensci.net/search?kw=1177-1062, scijournal=https://www.scijournal.org/impact-factor-of-MOL-DIAGN-THER.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.892, medsciHotlight=3.13, medsciHotlight5year=3.63354, citescore=0.0, hIndex=42, impactFactor=4.0, orgnization=Adis International Ltd, orgnizationUrl=http://www.adisonline.info/, country=United Kingdom, countryCn=英国, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|Current Contents - Life Sciences, bigclassCas=医学 3区, smallclassCas=医学 3 区, website=https://link.springer.com/journal/40291, websiteHits=6657, guideForAuthor=null, guideForAuthorHits=4, submitWebsite=https://www.editorialmanager.com/mdta/, submitWebsiteHits=2086, content=Published by Adis International Limited (now part of Wolters Kluwer Health). ISSN: 1177-1062.<br /><br />Combining the cutting-edge content of Molecular Diagnosis and the American Journal of Pharmacogenomics, Molecular Diagnosis & Therapy brings you independent and authoritative insights into the latest molecular diagnostic and pharmacogenomic techniques to improve the diagnosis and treatment of disease in patients in an individualized manner. The combined journal provides more comprehensive insight into: Using biomarkers to guide drug development, serve as diagnostics, and target medicines toward specific populations; Detection, monitoring and treatment of the molecular causes of disease; Molecular markers and genetic variation affecting drug response, drug metabolism, adverse effects and/or disease progression; Molecular disease classification; Drug/diagnostic combinations (theranostics); Emerging molecular diagnostic tools and technologies; Pathogen detection and drug resistance analysis; Ethical and regulatory issues relating to personalized medicine., totalCites=1793, brief=MOL DIAGN THER杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的偏低级别杂志, articleType=论著,综述各类型文章都接收, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=MOL DIAGN THER杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='//www.sandwebs.com/sci/submit.do?id=31f64957'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=71, tagName=分子诊断, createdHits=1), ImpactFactorTagDto(id=1455, tagName=病理, createdHits=1), ImpactFactorTagDto(id=1662, tagName=生物标志物, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.18), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.45), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.76), GetImpactFactorCiteScoreListResponse(year=2019, citescore=5.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=4.088), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=3.156), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=3.265), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=3.036), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.892)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=100/300), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Genetics , rank=123/318), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=77/165)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1177-1062[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=MOLECULAR DIAGNOSIS & THERAPY[ta], article_number=55, article_number_cn=5, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
MOL DIAGN THER/Molecular Diagnosis & Therapy
ISSN
1177-1062
影响指数话题
预警等级
MedSci期刊指数
2.892 (MedSci实时期刊指数) | 3.63354 (5年期刊指数)
CiteScore值
0.0
h-index
42
h5-median
暂无数据
出版社/管理机构
杂志由 Adis International Ltd 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Bimonthly
出版年份
2006
是否OA
被收录情况
Science Citation Index Expanded|Current Contents - Life Sciences
JCR分区
暂无数据
中科院分区
大类:医学 3区
小类:医学 3 区
Baidu
map
Baidu
map
Baidu
map